CDDO-TFEA

Chemical Name:

(4aS,6aR,6bS,12aS,14aR,14bR)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-N-(2,2,2-trifluoroethyl)-1,3,4,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydropicene-4a(2H)-carboxamide

SMILES Code: 

CC1(C)C2[C@@](C)(C3[C@](CC2)(C)[C@@]2(CC[C@]4(CCC(C)(C)C[C@]4([H])[C@@]2([H])C(=O)C=3)C(NCC(F)(F)F)=O)C)C=C(C#N)C1=O

InChi Code:

InChI=1S/C33H43F3N2O3/c1-27(2)10-12-32(26(41)38-18-33(34,35)36)13-11-31(7)24(20(32)16-27)21(39)14-23-29(5)15-19(17-37)25(40)28(3,4)22(29)8-9-30(23,31)6/h14-15,20,22,24H,8-13,16,18H2,1-7H3,(H,38,41)/t20-,22?,24+,29+,30-,31-,32+/m1/s1

InChi Key:

UBRASLQCAYTTEB-OROHISIGSA-N

Keyword:

932730-52-4；CAS：932730-52-4；CAS:932730-52-4；CDDO-TFEA；CDDO TFEA

Solubility: ≤5mg/ml in ethanol;5mg/ml in DMSO;5mg/ml in dimethyl formamide

Storage: Store at -20°C

Description: 

CDDO is an Nrf2 activator that can inhibit proliferation and induce differentiation and apoptosis of various cancer cells.

Target: Nrf2